No black box warning on record for Migergot

As of the latest FDA labeling reviewed, Migergot (ERGOTAMINE TARTRATE AND CAFFEINE) does not carry a black box warning. Standard warnings and precautions still apply — see the full Migergot medicine page for the complete safety profile.

Other warnings & precautions

WARNINGS CYP 3A4 Inhibitors (e.g. Macrolide Antibiotics and Protease Inhibitors) Coadministration of ergotamine with potent CYP 3A4 inhibitors such as protease inhibitors or macrolide antibiotics has been associated with serious adverse events; for this reason, these drugs should not be given concomitantly with ergotamine (See CONTRAINDICATIONS ). While these reactions have not been reported with

No black box warning on record for Migergot

Other warnings & precautions

WARNINGS CYP 3A4 Inhibitors (e.g. Macrolide Antibiotics and Protease Inhibitors) Coadministration of ergotamine with potent CYP 3A4 inhibitors such as protease inhibitors or macrolide antibiotics has been associated with serious adverse events; for this reason, these drugs should not be given concomitantly with ergotamine (See CONTRAINDICATIONS ). While these reactions have not been reported with

Migergot Black Box Warning

No black box warning on record for Migergot

Other warnings & precautions

Migergot Black Box Warning

No black box warning on record for Migergot

Other warnings & precautions